Pharmacological Inhibition of c‐Jun N‐Terminal Kinase Activity Exacerbates Liver Damage in Schistosoma mansoni Infected Mice
Frederik Stettler, Lukas Knedla, Maximilian Hagen, Verena von Bülow, Heike Müller, Annette Tschuschner, Daniel Zahner, Simone Haeberlein, Max F. Moescheid, Anita Windhorst, Monika Burg‐Roderfeld, Dieter Glebe, Bernardo Pereira Moreira, Céline Lesieur, Andreas Schmid, Franco H. Falcone, Christoph G. Grevelding, Elke Roeb, Martin RoderfeldABSTRACT
Background and Aims
Schistosomiasis is a neglected tropical disease affecting more than 250 million people worldwide. Eggs of the parasitic helminth
Methods
Eight‐week‐old male mice were infected with 100 cercariae (♂ + ♀) and 6 weeks later treated with SP600125 via a subcutaneously implanted osmotic pump over 3 weeks. Hepatic damage, inflammation, fibrosis and metabolic aspects were analysed in liver and spleen tissue as well as in serum samples.
Results
JNK inhibitor‐treated mice infected with
Conclusions
Our findings suggest a protective role of JNK/c‐Jun‐signalling in hepatic inflammation, hepatic stellate cell activation, and metabolic exhaustion during